Transforming genetic discoveries into groundbreaking treatments
We are accelerating the journey from genetic discovery to groundbreaking therapies in neurology, autoimmune diseases, and inflammatory skin conditions.
Our R&D efforts are operated by a team of international experts in genomics, bioinformatics, neurology, inflammation and immunology
– augmented by a world-class network of leading scientists and research institutions across the United States and Europe.
The Pulse
-
Icelandic drug discovery and development company Arctic Therapeutics (ATx) today announced the publication of research in JAMA Neurology, which informs a possible therapeutic strategy to treat a rare form of familial dementia. N-acetylcysteine (NAC) shows promise to treat hereditary cystatin C amyloid angiopathy (HCCAA) HCCAA – a subtype of cerebral amyloid…
Events
09 September
Nordic Life Science (NLS) Days15 October
Pharma Partnering US Summit